Image 1 — SRXH makes a bold investment
Image 2 — SRXH makes a bold investment
▲ 32 r/EMJX

SRXH makes a bold investment

I wanted to do a write-up on a company SRXH had just recently invested in called Greenland Mines Ltd (GRML)

From what I can tell, the company maintains a biotech pipeline targeting neurodegenerative diseases, specifically candidate KLTO-202 for Amyotrophic Lateral Sclerosis (ALS) and KLTO-101 for Alzheimer's disease, while simultaneously managing its flagship mining asset, the Skaergaard Project located in Southeast Greenland. Though geological reports estimate the Skaergaard deposit holds substantial potential mineral resources, including roughly 25.4 million ounces of Palladium Equivalent and 23.5 million ounces of Gold Equivalent, Greenland Mines Ltd operates with $0.00 in current revenue and faces severe capital-intensive extraction challenges due to the remote Arctic climate and a total lack of regional infrastructure.

To fund its operations and upcoming 2026 diamond drilling programs, Greenland Mines has aggressively sought external financing, raising $3.75 million through a private stock placement in mid-June 2026 before capturing the attention of institutional platforms.

On July 2, 2026, SRX Global, Inc. (NYSE American: SRXH), announced an investment into Greenland Mines Ltd. SRX Global deployed its capital to gain direct multi-asset exposure to the North Atlantic Critical Metals Corridor, betting on GRML’s potential to produce rare earth magnet materials and precious metals vital to technology and industrial manufacturing sectors.

This partnership directly links the financial trajectory of SRX Global and its shareholders to the high-risk, highly speculative exploration outcomes of a micro-cap hybrid entity carrying a market capitalization of approximately $35 million.

After my researching of the investment SRXH recently made, I personally see this as a better than I first expected investment. The chosen sector from a market shift standpoint is exactly where the market is shifting towards. We will see.

u/scsyndrome — 1 day ago

A quick reminder on MDAI volatility

If you are watching the price action today and feeling uneasy, just remember how these cycles work. Sharp drops on no negative company news are almost always designed to trigger stop-losses and shake out retail investors.
The big players rely on panic to accumulate cheaper shares. When volume gets erratic and the sentiment feels forced, it’s usually a sign to tune out the noise.
The fundamentals that made MDAI a high-conviction play haven't changed. Dips happen, but the long-term thesis remains exactly the same. Don't let a red day trick you into giving up your position right before the reversal.
Patience pays off. Know what you hold. Please don’t delete me! I mean well and support this company 100%.

reddit.com
u/scsyndrome — 1 month ago

10X Long Term Opportunity MRAM

You can listen to the earnings call from yesterday (May 11, 2026) by going to MRAM’s stock page on Robinhood and just click on the call.

Last night, I listened to MRAM’s earnings call that was released yesterday, and I am far more than impressed with what they had to say about the future of what’s to come. I highly suggest listening to this as I did prior to investing to better understand what to expect. I just thought I’d share this opportunity for the ones interested.

I am not yet invested . I’m hoping for a pull back, or for it to calm down a bit before I make my position because it’s going to be a very large position. They have over $40 million with no debt from what I gathered.

MRAM - 10x Material
To determine if MRAM (specifically Everspin) has "10-bagger" potential, we have to look at the math of the market cap versus the size of the industry it is trying to disrupt.
The short answer: Yes, the math supports a 10x move, but it requires MRAM to transition from a "niche" memory to a "standard" memory.
Here is how the path to a $10 Billion market cap (a 10x from current levels) looks:

  1. The Market Cap Math
    • Current State: ~$934 Million market cap (Price ~$40).
    • 10x Target: ~$9.3 Billion market cap (Price ~$400).
    • The Comparison: For perspective, Micron (DRAM) has a market cap of over $800 Billion. To 10x, Everspin only needs to capture roughly 1.2% of the total memory market. It doesn't need to kill DRAM; it just needs to become the standard for "Edge AI" and "Automotive."
  2. The Fundamental "Bridge" to 10x
    To get that 10x valuation, the company has to move from its current $64M annual revenue to roughly $600M - $1B in annual revenue. Management just told you on the call they want to hit $150M within 2–5 years.
    • The Catalyst: If they hit $150M and maintain their 50%+ gross margins, the market will likely award them a "growth multiple" (similar to ARM or NVIDIA). High-margin, high-moat semiconductor companies often trade at 10x–15x revenue.
    • The Math: $600M revenue × 15x multiple = $9 Billion Market Cap.
  3. Why it Could Actually Happen (The "Moat")
    • The "Universal Memory" Dream: MRAM is the only tech that combines the speed of SRAM, the density of DRAM, and the non-volatility of Flash. If the industry solves the "scaling" cost issue (which the 8nm/5nm eMRAM projects are doing), MRAM could replace several different types of chips on a single motherboard.
    • AI-Edge Dominance: In 2026, AI is moving into devices that don't have a plug (drones, wearable tech, satellites). These devices cannot use DRAM because it drains the battery just staying "awake." MRAM is the only viable alternative.
    • The "Buyout" Wildcard: At a sub-$1B valuation, a giant like Samsung, Intel, or Micron could try to buy the entire company just to own the patent portfolio. Usually, these buyouts happen at a 50%–100% premium, but if a bidding war starts, that’s where the "moonshot" returns happen.

*THE CEO DID MENTION DURING THE CALL THAT HE DOES NOT PLAN ON ACCEPTING ANY BUYOUTS AT THIS SPECIFIC TIME*

  1. The "Risk" to the 10x
    • The "Betamax" Risk: Even if MRAM is technically better, a competing tech (like ReRAM or FeRAM) could gain more industry momentum.
    • Foundry Bottlenecks: They rely on partners like GlobalFoundries and Microchip. If those partners prioritize other chips, Everspin's growth slows.

The Verdict for your Retirement Account
If you are looking at a 5 to 10-year horizon:

• DRAM (Micron): Likely a 2x or 3x move if the AI supercycle continues.
• MRAM (Everspin): A legitimate 10x candidate because it is starting from a much smaller "base" and has a fundamentally superior product for the future of AI.

If management hits that $150M target in the next few years, the market will re-rate this stock from a "speculative micro-cap" to a "critical semi leader."

reddit.com
u/scsyndrome — 2 months ago

TNYA has a strong look for 2026+

Key 2026 Developments & Financials
New Collaboration: In March 2026, Tenaya partnered with Alnylam Pharmaceuticals for cardiovascular genetic targets, receiving $10M upfront with potential for $1.1B in milestones.
Q1 2026 Results: Reported a narrowed quarterly loss of \(\$0.09\) per share compared to a \(\$0.24\) loss a year ago, with $0.23M in revenue.
Upcoming Data: Top-line results for TN-401 and TN-201 are expected to support registration pathways, aiming to address the root causes of inherited cardiomyopathies.
Cash Position: The company has strengthened its financial position following a late 2025 public offering and the new Alnylam partnership, extending its cash runway into the second half of 2027.

u/scsyndrome — 2 months ago